Dare Bioscience logo

Dare Bioscience

DARE | NASDAQ
Chart Builder DCF Calculator
$0.58
-$0.08 (-11.77%)
At close: Nov 16, 2026, 4:00 PM ET
$0.61
+$0.03 (+4.48%)
After-hours: Nov 16, 2026, 7:42 PM ET
-11.77%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
38.2
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #573/1021 (Top 56%)

Key Statistics

Market Data

Market Cap $8.75M
1D Range
0.58 0.70
52W Range
0.58 3.27

Valuation (TTM)

PE -0.73
PB -15.62
EV/EBITDA -0.34

Valuation (NTM)

Forward PE 0.17
Forward PEG 0.01
Price Target $1.50
Loading financial charts...

Profile

Daré Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XA...

Sector Healthcare
Industry Biotechnology
Employees 23
IPO Date Apr 10, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 16, 2026
EPS
-$0.18
Miss -42.10%
REV
$47.63K
Miss -97.66%
Next Earnings
Apr 1, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$1.50
Upside
+158.62%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.